Clinical Trials in San Francisco

Showing 12581-12600 of 12,991 trials

Motor-Point Stimulation for Conditioning the Diaphragm of Patients With Amyotrophic Lateral Sclerosis (ALS)

NCT00420719

The overall goal of this research is to delay the respiratory decline of patients with Amyotrophic Lateral Sclerosis (ALS) thereby increasing their lifespan by conditioning the diaphragm with laparoscopically placed electrodes. This device currently holds an Investigational Device Exemption No. G040142 in the United States and is currently undergoing clinical trials at University Hospitals (Cleveland), Johns Hopkins, Mayo Clinic Jacksonville, California Pacific Medical Center (CPMC), Henry Ford Health System, The Methodist Hospital, and Stanford University.

Amyotrophic Lateral Sclerosis (ALS)

Synapse Biomedical100 participantsStarted Oct 2004

San Francisco, California, United States • Stanford, California, United States • Jacksonville, Florida, United States +5 more locations

UNKNOWNPhase 2/3< 1 mile

ASCENT: Androgen Independent Prostate Cancer Study of Calcitriol Enhancing Taxotere

NCT00043576

The purposes of this study are to determine if DN-101 plus Taxotere lowers PSA levels, delays or limits disease progression and is safe with minimal side effects.

Prostate Cancer

Novacea250 participantsStarted Aug 2002

Montgomery, Alabama, United States • Scottsdale, Arizona, United States • Tucson, Arizona, United States +59 more locations

Motor-Point Stimulation for Conditioning the Diaphragm of Patients With Amyotrophic Lateral Sclerosis (ALS)

ASCENT: Androgen Independent Prostate Cancer Study of Calcitriol Enhancing Taxotere

Find Trials by Condition in San Francisco

Safety and Efficacy of Laparoscopic Truncal Vagotomy for the Treatment of Obesity

Temodar and Sutent as Therapy for Melanoma

A Study to Evaluate the Combination of Pegylated Interferon Alfa Plus Valopicitabine in Patients With Hepatitis C

Evaluation of Chronic HBV Patients w/Evidence of HBV Replication and Normal or Minimally Elevated Liver Transaminases.

To Determine if Olanzapine is More Cost Effective Than Haloperidol for the Treatment of Schizophrenia

Topical Alprostadil for Female Sexual Arousal Disorder

Study of AS1404 With Docetaxel in Patients With Hormone Refractory Metastatic Prostate Cancer

A Study Evaluating the Safety and Efficacy of Cura-100 in Subjects With Rheumatoid Arthritis and Osteoarthritis

CPG 7909 Injection in Non-Small Cell Lung Cancer

MIRAGE: Multi-Institutional Research in Alzheimer's Genetic Epidemiology

Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo & Active Control in Generalized Anxiety Disorder

Safety and Tolerance Study of Oral Doses of CT53518 to Treat Patients With Acute Myelogenous Leukemia (AML)

Lofexidine for Inpatient Opiate Detox

Efficacy and Safety of Quetiapine Fumarate Sustained Release (SEROQUEL SR) in Combination With an Antidepressant in the Treatment of Major Depressive Disorders

Phase 2 Study of MD-1100 Acetate Administered for 14 Days to Patients Meeting Criteria for Chronic Constipation

Safety, Tolerability, Immunological and Clinical Efficacy of Multiple Subcutaneous Doses of DiaPep277 in Latent Autoimmune Diabetes in Adults (LADA)

The Oscillation for ARDS Treated Early (OSCILLATE) Trial Pilot Study

Comparison of Eprosartan/HCT Versus Enalapril/HCT in Hypertensives With Type II Diabetes